Peptide Research Glossary.

A cellular energy sensor activated under low-ATP conditions. AMPK promotes catabolic energy production, fatty-acid oxidation, and mitochondrial biogenesis — a key target for peptides like MOTS-c.

A measure of total systemic exposure to a compound over time. AUC is the primary metric for comparing total dose impact between formulations.

Sterile water containing 0.9% benzyl alcohol as a preservative, used to reconstitute multi-use peptide vials. The benzyl alcohol prevents microbial growth across multiple withdrawals.

The fraction of an administered compound that reaches systemic circulation in its active form. Subcutaneous peptide bioavailability is typically 60–90% depending on molecular weight and formulation.

The maximum plasma concentration reached after a single dose. Cmax is a key marker for comparing absorption profiles across delivery routes.

An uninterrupted refrigerated supply route from manufacturer to end-use. Critical for peptide stability — most lyophilised peptides require 2–8°C storage and reconstituted solutions require freezing for long-term integrity.

A peptide bound to a copper ion that modulates tissue remodelling, angiogenesis, and dermal regeneration. GHK-Cu and AHK-Cu are the most studied examples.

A defined research period during which a compound is administered and observed, typically followed by a washout interval to assess persistence and clearance.

A framework used by search engines to evaluate content quality. In peptide research, citing peer-reviewed sources and clearly stating research-only context strengthens E-E-A-T signals.

A hypothalamic peptide that stimulates the anterior pituitary to release endogenous growth hormone. GHRH analogues such as CJC-1295 and tesamorelin are widely studied in regenerative and metabolic protocols.

The receptor activated by ghrelin and ghrelin-mimetic peptides (e.g., ipamorelin), driving pulsatile growth hormone release without significantly elevating cortisol or prolactin.

An incretin hormone released from the small intestine that amplifies post-prandial insulin response and modulates adipose tissue lipid handling. Co-targeted with GLP-1 in dual- and triple-agonist research peptides.

An incretin hormone that enhances glucose-dependent insulin secretion, slows gastric emptying, and reduces appetite. GLP-1 receptor agonists are a foundational class in modern metabolic peptide research.

A G-protein-coupled receptor primarily expressed in the liver. Activation increases hepatic glucose output and basal energy expenditure — a key axis in triple-agonist metabolic research.

The time required for the concentration of a compound in a system to fall to half its initial value. Half-life directly informs dosing frequency in research protocols.

A class of peptides that mimic endogenous incretin hormones (GLP-1, GIP) to enhance glucose-dependent insulin secretion. Includes mono-, dual-, and triple-agonist research compounds.

Delivery directly into muscle tissue, producing faster absorption and higher peak concentration than subcutaneous routes.

A standardised unit of measurement based on biological activity rather than mass. On a U-100 insulin syringe, 100 IU equals 1 mL — central to accurate research dose calculation.

Freeze-drying under vacuum to produce a stable, water-free peptide powder. Lyophilised peptides have dramatically extended shelf life compared to solution-form analogues.

A family of G-protein-coupled receptors regulating pigmentation (MC1R) and energy balance / sexual function (MC4R). Targeted by melanocortin analogues such as PT-141 and Melanotan II.

A short peptide encoded within the mitochondrial genome (e.g., MOTS-c, humanin) that modulates metabolic and stress-response pathways across tissues.

A central kinase that integrates nutrient, energy, and growth-factor signals to regulate protein synthesis, autophagy, and cellular ageing. A foundational pathway in longevity and recovery research.

A peptide studied for cognitive, attentional, or neuroprotective effects. Examples include Semax (BDNF/dopaminergic) and Selank (anxiolytic / immune-modulating).

The interval between administration of a compound and the first measurable physiological effect. Determined by absorption rate, route, and receptor binding kinetics.

Hormonal secretion in discrete bursts rather than continuous flow — a defining feature of physiological growth hormone release that several peptide classes attempt to mimic.

A molecule that binds to a receptor and activates it, producing a biological response. Triple agonists (e.g., retatrutide) bind and activate three distinct receptor classes simultaneously.

A molecule that binds to a receptor without activating it, blocking other ligands from producing a response. Used as research tools for isolating receptor contribution.

The process of dissolving a lyophilised (freeze-dried) peptide in a sterile diluent — typically bacteriostatic water — to produce a usable research solution.

A compound that stimulates the secretion of another substance — most commonly used to describe peptides that trigger endogenous growth hormone release (e.g., ipamorelin, hexarelin).

Delivery into the layer of tissue directly beneath the skin. The most common research route for peptides — slower absorption than IM, but more consistent and less invasive.

The time at which Cmax (peak concentration) is observed. Useful for predicting onset of action across different peptide classes.